Last reviewed · How we verify

NCT04733898

Social Health Games: The Use of Online Games to Decrease Loneliness in Older Adults

Terminated NA Last updated 31 March 2023
What this trial tests

NA trial testing SamenSpelen.app in Loneliness in 76 participants. Terminated before completion.

Timeline
1 April 2021
Primary endpoint
28 March 2022
28 March 2022

Quick facts

Lead sponsorRadboud University Medical Center
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment76
Start date1 April 2021
Primary completion28 March 2022
Estimated completion28 March 2022
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Radboud University Medical Center

Who can join

65 and older, any sex, with Loneliness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines whether social platform games are effective in expanding the social network and decreasing the experienced levels of loneliness in older adults. The newly developed social games will be compared to non-personal games and not playing games.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Digital Gaming Intervention to Strengthen the Social Networks of Older Dutch Adults: Mixed Methods Process Evaluation of a Digitally Conducted Randomized Controlled Trial.
    Janssen J, Châtel B, Den Heijer N, Tieben R, et al · · 2023 · cited 2× · PMID 37862093 · DOI 10.2196/45173

Verify or expand the search:

Other recruiting trials for Loneliness

Currently open trials in the same condition.

Other Radboud University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04733898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing